Odyssey Health, Inc. 8-K

What Happened

• Odyssey Health, Inc. (ODYY) filed an 8-K reporting multiple amendments to existing convertible and promissory notes. On January 30, 2026 the company entered Amendment No. 12 agreements for notes originally dated December 21 and December 22, 2021 with two directors and two officers, extending those notes’ maturities to January 31, 2027.
• Also on January 30, 2026 the company entered Amendment No. 11 to a note with LGH Investments, LLC, extending that note’s maturity to April 30, 2026. Amendment No. 5 to the February 13, 2024 note with accredited investor Jonathan Lutz similarly extended that note’s maturity to January 31, 2027. On February 2, 2026 (effective January 31, 2026) the company entered Amendment No. 2 with accredited investor Peter J. D’Arruda, extending that note’s maturity to January 31, 2027. The amendment documents are filed as Exhibits 10.1–10.4 to the report.

Key Details

• Parties: two directors and two officers (for the 2021 notes), LGH Investments, LLC; accredited investors Jonathan Lutz and Peter J. D’Arruda.
• New maturities: most amended notes now mature January 31, 2027; the LGH Investments note matures April 30, 2026.
• Amendment dates: majority dated January 30, 2026; the D’Arruda amendment dated February 2, 2026 and effective January 31, 2026.
• Documents: Amendment forms are attached as Exhibits 10.1–10.4 to the Form 8-K.

Why It Matters

• These amendments change Odyssey Health’s near-term debt schedule by deferring repayment or conversion deadlines for several notes. For investors, the extensions reduce the immediate cash or conversion pressure on the company through early 2026 and into 2027, and they reflect negotiated terms with insiders and outside noteholders. The filed exhibits provide the specific amendment terms for anyone who wants to review the legal details.